Aveanna Healthcare Holdings, Inc.
AVAHNasdaqCIK 1832332HealthcareFiscal year ends Jan 1
Reports and events: 111 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0220:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-412540 |
| 2026-08-2420:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363654 |
| 2026-08-1311:00 ET | 10-Q | Quarterly reportPeriod 2026-07-04 | 0001193125-26-347842 |
| 2026-08-1311:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347840 |
| 2026-08-1311:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347839 |
| 2026-08-0720:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-340409 |
| 2026-06-0211:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252511 |
| 2026-05-2920:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-248323 |
| 2026-05-2812:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-243028 |
| 2026-05-1512:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-225430 |
| 2026-05-1411:00 ET | 10-Q | Quarterly reportPeriod 2026-04-04 | 0001193125-26-222736 |
| 2026-05-1411:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222735 |
| 2026-04-1720:30 ET | DEF 14A | Proxy statementPeriod 2026-05-29 | 0001193125-26-161632 |
| 2026-03-2011:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001832332-26-000002 |
| 2026-03-1919:33 ET | 10-K | Annual reportPeriod 2026-01-03 | 0001193125-26-115851 |
| 2026-03-1911:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-115114 |
| 2026-03-1211:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-103067 |
| 2026-02-2721:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-082823 |
| 2026-02-2021:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-061523 |
| 2026-01-1413:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-012301 |
| 2025-11-1421:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-282983 |
| 2025-11-0712:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-271016 |
| 2025-11-0611:30 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0001193125-25-267978 |
| 2025-11-0611:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-267977 |
| 2025-10-2320:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-248773 |
| 2025-10-2120:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-245131 |
| 2025-09-2921:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-223435 |
| 2025-09-1811:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-206824 |
| 2025-08-1100:00 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-06-28 | 0000950170-25-106110 |
| 2025-08-0813:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-105493 |
| 2025-08-0710:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-104525 |
| 2025-08-0710:30 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0000950170-25-104528 |
| 2025-06-2711:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-090612 |
| 2025-06-0411:30 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-081394 |
| 2025-05-0919:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-067908 |
| 2025-05-0911:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-067501 |
| 2025-05-0810:30 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0000950170-25-066342 |
| 2025-05-0810:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-066341 |
| 2025-04-0311:11 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-049951 |
| 2025-03-2821:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-046956 |
| 2025-03-2520:06 ET | DEF 14A | Proxy statementPeriod 2025-05-09 | 0001193125-25-062528 |
| 2025-03-1411:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-039119 |
| 2025-03-1317:13 ET | 10-K | Annual reportPeriod 2024-12-28 | 0000950170-25-038504 |
| 2025-03-1310:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-038316 |
| 2024-11-0812:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-123696 |
| 2024-11-0711:33 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0000950170-24-122748 |
| 2024-11-0711:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122743 |
| 2024-11-0412:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-120285 |
| 2024-10-0420:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-112939 |
| 2024-08-0910:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-094335 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.